Replies to post #894 on Trius Therapeutics, Inc. (TSRX)

[noretreat]

consensus as of a while back was around 35m 2015, 62M 2016, 148m 2018 rising to 300m in 2020.

I have not followed it real closely since it got absorbed into the behemoth that is Merck. the rumor, of course, is that Merck will hold the drug back to avoid the CVR payments...in my view that would be counterproductive. I sold everything out after the Cubist buyout was announced so I hold no CVRs